Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs VTEB✓SelectedUSD · VTEBGSK vs VTEB performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs VTEB

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+108.5%
VTEB return
+26.7%
Excess return
+81.8%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioVTEBExcessAlpha
1D-0.1%+0.4%-0.5%-0.4%
7D-5.3%-0.1%-5.2%-5.2%
30D-3.7%+1.5%-5.2%-4.8%
3M-7.3%-1.1%-6.1%-6.3%
6M-4.2%-0.7%-3.5%-3.6%
YTD+0.9%-0.6%+1.4%+1.5%
1Y+7.3%-0.2%+7.5%+7.6%
3Y+52.7%+8.9%+43.8%+43.5%
5Y+40.1%+2.4%+37.7%+37.1%
10Y+98.7%+23.5%+75.2%+107.6%
All+108.5%+26.7%+81.8%+130.8%

Cumulative growth

Daily Returns

Daily percentage return beside VTEB.

Daily Out/Under-Performance

Portfolio return minus VTEB return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × VTEB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded VTEB wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling